Sector ratings Bright Minds Biosciences Inc.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 20:49:39 05/06/2026 BST			5-day change	1st Jan Change
96.12 ^CAD	0.00%		-22.14%	-12.96%

05-19	Bright Minds Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026	CI
04-08	Certain RSUs of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026.	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
BRIGHT MINDS BIOSCIENCES INC.	677M	-	-	-		-
LONZA GROUP AG	42.68B		AAA
REVOLUTION MEDICINES, INC.	31.73B	-	B	-		-
IQVIA HOLDINGS INC.	30.62B		AAA
BEONE MEDICINES AG	30.03B		-
CELLTRION, INC.	24.25B		A
EUROFINS SCIENTIFIC SE	13.17B		AA
ASCENDIS PHARMA A/S	13.07B	-	-	-		-		-
MEDPACE HOLDINGS, INC.	12.97B		BBB
IONIS PHARMACEUTICALS, INC.	12.31B	-	A	-		-
ICON PUBLIC LIMITED COMPANY	11.44B		AAA
REGENCELL BIOSCIENCE HOLDINGS LIMITED	9.9B	-	-	-	-	-	-	-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	8.73B		AA
TEMPUS AI, INC.	8.34B		A			-
BIO-TECHNE CORPORATION	8.14B		AA
ABIVAX	8.08B	-	BBB	-		-
QIAGEN N.V.	7.59B		AAA
ALKERMES PLC	7.13B		A
PRAXIS PRECISION MEDICINES, INC.	7.08B	-	B	-		-
APOGEE THERAPEUTICS, INC.	6.51B	-	B	-		-
Average	14.72B		A
Weighted average by Cap.			A